Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Active not recruiting 4Unknown 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Disease 1

Interventions

Oxaliplatin 87Bevacizumab 68Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 41Drug Therapy 41Leucovorin 38sintilimab 36Irinotecan 35lenvatinib 28Cisplatin 27HMPL-013 24S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20Paclitaxel 19130-nm albumin-bound paclitaxel 19toripalimab 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14Radiosurgery 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nutrition Assessment × Gastrointestinal × Clear all
NCT07201857 2025-10-01

Peri-habilitation for Patients With Gastric Cancer

Korea University Anam Hospital

Phase NA Not yet recruiting
30 enrolled
Gastrointestinal

Disease, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡